239 related articles for article (PubMed ID: 26756896)
1. Performance assessment of the Thai National Center for Pharmacovigilance.
Kaewpanukrungsi W; Anantachoti P
Int J Risk Saf Med; 2015; 27(4):225-37. PubMed ID: 26756896
[TBL] [Abstract][Full Text] [Related]
2. Pharmacovigilance activities in ASEAN countries.
Suwankesawong W; Dhippayom T; Tan-Koi WC; Kongkaew C
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1061-9. PubMed ID: 27174034
[TBL] [Abstract][Full Text] [Related]
3. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
[TBL] [Abstract][Full Text] [Related]
4. [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010].
N'Guessan-Irié AG; Yavo JC; Guillaume Amari AS; Yapi AD
Therapie; 2012; 67(3):251-6. PubMed ID: 22874492
[TBL] [Abstract][Full Text] [Related]
5. The Erice Manifesto: for global reform of the safety of medicines in patient care.
Drug Saf; 2007; 30(3):187-90. PubMed ID: 17343426
[TBL] [Abstract][Full Text] [Related]
6. Aggregate analysis of regulatory authority assessors' comments to improve the quality of periodic safety update reports.
Jullian S; Jaskiewicz L; Pfannkuche HJ; Parker J; Lalande-Luesink I; Lewis DJ; Close P
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):971-9. PubMed ID: 26175055
[TBL] [Abstract][Full Text] [Related]
7. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.
Bergvall T; Norén GN; Lindquist M
Drug Saf; 2014 Jan; 37(1):65-77. PubMed ID: 24343765
[TBL] [Abstract][Full Text] [Related]
8. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
[TBL] [Abstract][Full Text] [Related]
9. Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processes.
Laroche ML; Batz A; Géniaux H; Féchant C; Merle L; Maison P
Therapie; 2016 Apr; 71(2):161-9. PubMed ID: 27080834
[TBL] [Abstract][Full Text] [Related]
10. Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008.
Saokaew S; Suwankesawong W; Permsuwan U; Chaiyakunapruk N
Drug Saf; 2011 Apr; 34(4):339-50. PubMed ID: 21417506
[TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance in oncology: evaluation of current practice and future perspectives.
Baldo P; De Paoli P
J Eval Clin Pract; 2014 Oct; 20(5):559-69. PubMed ID: 24909067
[TBL] [Abstract][Full Text] [Related]
12. Good pharmacovigilance practices: technology enabled.
Nelson RC; Palsulich B; Gogolak V
Drug Saf; 2002; 25(6):407-14. PubMed ID: 12071777
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a new pharmacovigilance tool: Simplified online reporting for general practitioners].
Humbert X; Chrétien B; Sassier M; Coquerel A; Alexandre J; Fedrizzi S
Sante Publique; 2018; 30(2):225-232. PubMed ID: 30148310
[TBL] [Abstract][Full Text] [Related]
15. [The new pharmacovigilance legislation in practice].
Broekmans AW; Mol PG
Ned Tijdschr Geneeskd; 2014; 158():A7129. PubMed ID: 24846112
[TBL] [Abstract][Full Text] [Related]
16. Drug Safety Evaluation in China.
Li L; Yin J
Curr Allergy Asthma Rep; 2019 Jul; 19(9):39. PubMed ID: 31321555
[TBL] [Abstract][Full Text] [Related]
17. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
[TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance: methods, recent developments and future perspectives.
Härmark L; van Grootheest AC
Eur J Clin Pharmacol; 2008 Aug; 64(8):743-52. PubMed ID: 18523760
[TBL] [Abstract][Full Text] [Related]
19. Evolving paradigms in pharmacovigilance.
Brewster W; Gibbs T; Lacroix K; Murray A; Tydeman M; Almenoff J
Curr Drug Saf; 2006 May; 1(2):127-34. PubMed ID: 18690923
[TBL] [Abstract][Full Text] [Related]
20. [The French pharmacovigilance system: structure and missions].
Welsch M; Alt M; Richard MH; Imbs JL
Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
